PDS Biotechnology to Present Recent Phase 2 Human Clinical Data and On-Going Oncology Programs at Investor Conferences

NEXT STORY
Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
PREV STORY
Research Antibodies Market Research Report by Function, by Operation, by Product, by Source, by Technology, by Type, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agios Announces Pricing of $256 Million Public Offering of Common Stock

author_avatar
NASDAQ Market News

Biocartis Group NV: Biocartis lanceert innovatieve Idylla(TM) MSI Test

  PERSBERICHT: 17 juli 2018, 07:00 CEST   Biocartis lanceert innovatieve Idylla(TM) MSI Test ...

author_avatar
NASDAQ Market News

Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Overall Response Rate (ORR) of 70% and 6-month Progression Free Survival (PFS) rate of ...

author_avatar
NASDAQ Market News